RFX | REFE Company Overview, Contact Details & Competitors

Q: What is RFX | REFE's official website and social media links?

RFX | REFE's official website is shiprfx.com. RFX | REFE has social profiles on LinkedIn.

Q: How many employees does RFX | REFE have currently?

RFX | REFE has approximately 201 employees.

Q: What technology does RFX | REFE use?

RFX | REFE's tech stack includes Google Fonts API, HubSpot, RSS, Apache, X-Content-Type-Options.

Insights

Gathering insights about RFX | REFE…

Similar companies to RFX | REFE

RFX | REFE Tech Stack

RFX | REFE uses 8 technology products and services including CIM Technologies, Font Awesome, Slick, and more. Explore RFX | REFE's tech stack below.

CIM Technologies
Cad & Graphics
Font Awesome
Font Scripts
Slick
Javascript Libraries
HubSpot
Marketing Automation
Microsoft
Miscellaneous
Cloudflare Bot Management
Security
X-Content-Type-Options
Web & Portal Technology
Smush
Web Tools And Plugins

Media & News

Nvidia enrollment sends this stock soaring 130%
Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program.
Aug 19, 2025 | finbold.com
PainReform/DeepSolar Accepted into NVIDIA Connect Program
Acceptance to NVIDIA Connect Program offers access to unique tools for the development of DeepSolar's nextgen, AI-driven, solar forecasting platform to improve weather prediction accuracy by up to 50% and optimize energy asset performance Acceptance to NVIDIA Connect Program offers access to unique tools for the development of DeepSolar's nextgen, AI-driven, solar forecasting platform to improve weather prediction accuracy by up to 50% and optimize energy asset performance
Aug 19, 2025 | www.globenewswire.com
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
Acquisition of Majority Equity Interest in LayerBio and its OcuRing™-K Technology Targets Growing Demand for ‘Dropless' Solutions in Ophthalmic Surgery Acquisition of Majority Equity Interest in LayerBio and its OcuRing™-K Technology Targets Growing Demand for ‘Dropless' Solutions in Ophthalmic Surgery
Aug 13, 2025 | www.globenewswire.com
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio
TEL AVIV, Israel, July 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate treatments for ophthalmic surgery.
Jul 10, 2025 | www.globenewswire.com
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel , May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).
May 27, 2025 | www.prnewswire.com
PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects
TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced the launch of a strategic pilot program with Econergy Renewable Energy Ltd., a leading European independent power producer (IPP). The project will utilize PainReform's proprietary DeepSolar™ platform, an AI-powered optimization solution designed to enhance operational efficiency and energy yield at utility-scale solar facilities. The pilot will be conducted at Econergy's 92-megawatt (MW) photovoltaic plant in Parau, Romania—one of the country's largest operational solar projects.
May 07, 2025 | www.globenewswire.com
PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market
TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company and developer of AI-powered energy optimization technologies, today announced its official expansion into the rapidly growing Smart Energy Management (SEM) sector. This move follows the successful acquisition of DeepSolar, a cutting-edge provider of AI-driven software solutions designed to optimize solar energy usage in residential and utility-scale solar power plants.
Apr 10, 2025 | www.globenewswire.com

RFX | REFE's Email Address Formats

RFX | REFE uses at least 2 format(s):

RFX \| REFE Email Formats	Example	Percentage
F.Last@rfxinc.com	J.Doe@rfxinc.com	99%
FirstL@rfxinc.com	JohnD@rfxinc.com	1%
First@shiprfx.com	John@shiprfx.com	67%
First.Last@shiprfx.com	John.Doe@shiprfx.com	20%
FirstL@shiprfx.com	JohnD@shiprfx.com	9%
FirstLast@shiprfx.com	JohnDoe@shiprfx.com	4%

Frequently Asked Questions

What is RFX | REFE's stock symbol?

RFX | REFE is a publicly traded company; the company's stock symbol is PRFX.

What is RFX | REFE's official website and social media links?

RFX | REFE's official website is shiprfx.com and has social profiles on LinkedIn.

What is RFX | REFE's NAICS code?

RFX | REFE's NAICS code is 48-49 - Transportation and Warehousing.

How many employees does RFX | REFE have currently?

As of December 2025, RFX | REFE has approximately 201 employees across 2 continents, including North AmericaSouth America. Key team members include Chief Capacity & Sales Officer: R. N.Chief Financial Officer: J. G.Chief Operating Officer: D. R.. Explore RFX | REFE's employee directory with LeadIQ.

What industry does RFX | REFE belong to?

RFX | REFE operates in the Transportation, Logistics, Supply Chain and Storage industry.

What technology does RFX | REFE use?

RFX | REFE's tech stack includes CIM TechnologiesFont AwesomeSlickHubSpotMicrosoftCloudflare Bot ManagementX-Content-Type-OptionsSmush.

What is RFX | REFE's email format?

RFX | REFE's email format typically follows the pattern of F.Last@rfxinc.com. Find more RFX | REFE email formats with LeadIQ.

When was RFX | REFE founded?

RFX | REFE was founded in 1952.

Insights

Similar companies to RFX | REFE

REF

FER

RTX

Rex

RFX | REFE Tech Stack

Media & News

Nvidia enrollment sends this stock soaring 130%

PainReform/DeepSolar Accepted into NVIDIA Connect Program

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

RFX | REFE's Email Address Formats

Frequently Asked Questions

What is RFX | REFE's stock symbol?

What is RFX | REFE's official website and social media links?

What is RFX | REFE's NAICS code?

How many employees does RFX | REFE have currently?

What industry does RFX | REFE belong to?

What technology does RFX | REFE use?

What is RFX | REFE's email format?

When was RFX | REFE founded?

RFX | REFE

Company Overview

Media & News

Nvidia enrollment sends this stock soaring 130%

PainReform/DeepSolar Accepted into NVIDIA Connect Program

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?